Aldo-Keto Reductases Are Biomarkers of NRF2 Activity and Are Co-Ordinately Overexpressed in Non-Small Cell Lung Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2017.80
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeting Angiogenesis in Advanced Non-Small-Cell Lung Cancer: Are Biomarkers Needed?

Current Respiratory Care Reports
2013English

Circulating Microparticles Are Prognostic Biomarkers in Advanced Non-Small Cell Lung Cancer Patients

Oncotarget
Oncology
2017English

Aldo-Keto Reductases 1B in Adrenal Cortex Physiology

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2016English

Regulation of Aldo–Keto Reductases in Human Diseases

Frontiers in Pharmacology
Pharmacology
2012English

Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2006English

Emerging Roles of Nrf2 Signal in Non-Small Cell Lung Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

CNTF and Nrf2 Are Co-Ordinately Involved in Regulating Self-Renewal and Differentiation of Neural Stem Cell During Embryonic Neural Development

iScience
Multidisciplinary
2019English

Cellular Protoonocogenes Are Infrequently Amplified in Untreated Non-Small Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
1989English

Polymorphisms in MicroRNAs Are Associated With Survival in Non-Small Cell Lung Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy